government
FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr.
Summary by The Los Angeles Editorial Desk · Based on reporting by Matthew Perrone | The Associated Press , NBC Los Angeles (KNBC)
· July 23, 2026
· 5 min read
A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals haven’t been shown safe or effective. In a series of votes, outside experts to th...
Story provenance No corrections
Summary created by The Los Angeles Editorial Desk — automated, rule-governed Original reporting Matthew Perrone | The Associated Press, NBC Los Angeles (KNBC) Original story Read at the source Source published Jul 23, 2026 Indexed here Jul 23, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway In a series of votes, outside experts to the Food and Drug Administration advised the agency to drop current restrictions barring pharmacies from producing injectable peptides with names like BPC-157, TB-500 and KPV.
Why this matters
Local government decisions — zoning, budgets, ordinances, contracts — shape daily life more than most national headlines. The Los Angeles surfaces these stories so readers can engage with the bodies that affect their property, taxes, and neighborhood character.
About this story
Original reporting by NBC Los Angeles (KNBC) . The Los Angeles surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit NBC Los Angeles (KNBC) . Have a tip or correction? Contact our newsroom .
Category: government ·
Published: July 23, 2026 ·
Source: NBC Los Angeles (KNBC) ·
Reading time: 5 min
Frequently asked about this story
What is this story about? A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals haven’t been shown safe or effective. In a series of votes, outside experts to th...
When was this published? This article was first published on July 23, 2026 by NBC Los Angeles (KNBC) and curated for The Los Angeles readers.
Who reported this story? This story was reported by Matthew Perrone | The Associated Press at NBC Los Angeles (KNBC). To learn more about how The Los Angeles selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more government coverage from The Los Angeles, or browse our daily briefing and topic hubs .
← Back to all news
More government →
Today’s briefing
Subscribe to newsletter